New stock news | Jin Xun shares re-submitted to Hong Kong Stock Exchange
According to the disclosure by the Hong Kong Stock Exchange on December 1st, Yunnan Jin Xun Resources Co., Ltd. has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with Huatai International as the exclusive sponsor.
According to the disclosure on December 1 by the Hong Kong Stock Exchange, Yunnan Jin Xun Resources Co., Ltd. (referred to as Jin Xun Shares) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with Huatai International as the exclusive sponsor. Earlier, the company had submitted a filing to the Hong Kong Stock Exchange on June 1, 2025. According to the prospectus, Jin Xun Shares is a leading manufacturer of high-quality cathode copper, focusing on the development and supply of high-quality copper resources to meet China's huge demand for copper. The company utilizes the abundant copper reserves in Africa, strategically expanding its production capacity and achieving deep integration of the entire industry value chain.
As of December 31, 2024, based on production in the Democratic Republic of the Congo and Zambia, the company ranks fifth among Chinese cathode copper producers and is the only Chinese company ranking in the top five in both jurisdictions. Specifically, in 2024, the company produced approximately 16,000 tons of cathode copper in the Democratic Republic of the Congo and 5,000 tons in Zambia. Among private enterprises in China, based on 2024 production figures, the company ranks third in the Democratic Republic of the Congo and first in Zambia.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.

CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.

GMTEight List of A-share restricted sales and lifting restrictions | December 8th






